Andrew Farquharson

Andrew holds an MBA from Harvard University and a Bachelor's, with High Honors, from the University of California at Berkeley.

Andrew is an investor and entrepreneur with two decades of success shaping and building companies in life sciences. The co-founder of VentureHealth and InCube Ventures, his passion is biomedical innovation that dramatically improves lives. Andrew's current board seats include Channel Medsystems, Rani Therapeutics, and Sonoma Orthopedic Products, among others. 

​

Prior to joining InCube, Andrew was an active investor with The Angels' Forum and a Partner in the Halo Funds, where he completed his Fellowship and led investments in a portfolio of life science firms. These investments include Intrapace (obesity), Penumbra (ischemic stroke), Sonoma Orthopedic Products, SwitchGear Genomics & Spinal Modulation (pain management). 

​

Prior to becoming a professional investor, Andrew helped to build Operon Technologies into the world's most successful DNA synthesis company, then became a member of the senior executive team within QIAGEN. He began his career at Genentech, where he led teams in various operational and research roles.

Andrew is a member of Kauffman Fellows Class 9 and served his fellowship under mentor Phil Schlein at The Angels' Forum/Halo Funds. He served as a mentor to Mar Perez (Class 19) and Terence Lam (Class 23).